Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell death–inducing DNA fragmentation factor alpha-like effector C (CIDEC) is a protein primarily involved in lipid metabolism and adipocyte biology. It promotes unilocular lipid droplet formation by mediating lipid droplet fusion within adipocytes and acts as a regulator of adipocyte lipid metabolism, facilitating optimal energy storage. Dysregulation or altered expression of CIDEC has been implicated in several metabolic disorders, including obesity, type 2 diabetes, and non-alcoholic fatty liver disease. Alterations at the genomic locus containing CIDEC have been observed in some cancers, suggesting broader roles beyond metabolism alone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell death-inducing DNA fragmentation factor alpha-like effector C (CIDEC).